DESIGN OF A PHARMACEUTICAL FORMULATION: DEVELOPMENT AND CHARACTERIZATION OF GUATTERIOPSISCINE INCLUSION COMPLEX WITH β-CYCLODEXTRIN

Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2019, Vol 8, Issue 4

Abstract

The species Guatteria friesiana (W. A. Rodrigues) Erkens & Maas, known as "envireira", is a plant native to Brazil, found particularly in the Amazon region. This plant has important active ingredients, such as the essential oil constituents of leaves and their alkaloids. In other studies, G. friesiana has been shown to have antimicrobial activity, and no cytotoxic effect. In our search for new inhibitors of the acetylcholinesterase enzyme, some alkaloids isolated from G. friesiana were tested in vitro and one of these alkaloids, guatteriopsiscine, showed a promising anticholinesterase activity superior to the standard drug, rivastigmine. However, guatteriopsiscine has a crystalline profile, which suggests a lower solubility in relation to an amorphous compound. Therefore, the search for an efficient and non-toxic carrier for the guatteriopsiscine has important clinical application, the pharmaceutical excipient cyclodextrin can be mentioned as an example of this carrier. This study aimed to obtain and characterize inclusion complexes of guatteriopsiscine with β-cyclodextrin (β-CD). This preparation was done using the technique of malaxation and this characterization was done through several techniques, namely: infrared spectroscopy, thermogravimetric analysis, X-ray diffraction, scanning electron microscopy, nuclear magnetic resonance of hydrogen and tests of dissolution. These techniques confirmed the formation of inclusion complexes between guatteriopsiscine and β-CD. Therefore, the results obtained are promising for the preparation of a future pharmaceutical formulation with that complex.

Authors and Affiliations

Valéria Lima Silva Veras

Keywords

Related Articles

‘COLD’ CURTAILS THE PAIN IN ENDODONTICS?

In general, pain is defined as an “unpleasant sensory & emotional experience associated with actual or potential tissue damage”. Tooth pain is one of the most dreaded experiences cited by most people and a significant nu...

PREMATURE EVENTS IN CHIKUNGUNYA VIRUS INFECTION AND THEIR INHIBITING STRATEGIES—FROM VIRUS CELL BINDING TO MEMBRANE FUSION

Chikungunya virus is a rapidly emerging mosquito-borne alphavirus causing millions of infections in the tropical and subtropical regions of the world. This infection often leads to an acute self-limited febrile illness w...

A REVIEW ON MEDICINAL PROPERTIES OF LANTANA CAMARA LINN

Lantana camara is well known to cure several diseases and used in various folk medicinal preparations. In last few decades, scientist and researchers around the globe have elaborately studied the chemical composition of...

DESIGN, DEVELOPMENT AND EVALUATION OF LOMEFLOXACIN HYDROCHLORIDE NIOSOMAL GUM BASED IN SITU GELS FOR OTIC DRUG DELIVERY

The aim of the present study was to design, formulate and evaluate lomefloxacin Hcl niosomal in situ gels to provide broad spectrum antibacterial activity for the treatment of ear infections aiming to increase drug conce...

THE SYNTHESIS OF DIFFERENT DERIVATIVES OF ARTEMISININ FOR THE TREATMENT OF MALARIA

The present review will put a light on the various approaches for the treatment of malaria. The focus will be on the synthesis of various derivatives for the treatment of malaria. Some of the derivatives discussed in the...

Download PDF file
  • EP ID EP667353
  • DOI -
  • Views 167
  • Downloads 0

How To Cite

Valéria Lima Silva Veras (2019). DESIGN OF A PHARMACEUTICAL FORMULATION: DEVELOPMENT AND CHARACTERIZATION OF GUATTERIOPSISCINE INCLUSION COMPLEX WITH β-CYCLODEXTRIN. WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE, 8(4), 79-96. https://europub.co.uk/articles/-A-667353